Carcinoid tumors of the thymus and Cushing's syndrome: Clinicopathologic features and current best evidence regarding the cell of origin of these unusual neoplasms

Ann Diagn Pathol. 2019 Feb:38:71-79. doi: 10.1016/j.anndiagpath.2018.11.006. Epub 2018 Nov 22.

Abstract

It is uncertain whether thymic neuroendocrine tumors (NET) associated with Cushing's syndrome (CS) produce corticotropin-releasing hormone (CRH) and adrenocorticotropin hormone (ACTH) and whether the thymus contains ACTH and/or CRH cells that could originate NET. The clinicopathologic features of 5 typical (TC) and 6 atypical carcinoids (ATC), 10 additional non-neoplastic thymi, 6 adrenal glands with bilateral nodular hyperplasia and 8 adrenal cortical adenomas were reviewed. Representative slides were immunostained for ACTH and CRH. Four (36.4%) of the 11 patients had CS. The incidence of Masaoka stage IV was higher (p < 0.0001) in patients with ATC than TC. Only 2 (18.1%) of the 11 patients were alive at follow-up. Ten NET were CRH immunoreactive and 6 were ACTH immunoreactive. Thymic NET with CS exhibited stronger immunoreactivity for ACTH and CRH than those without CS. Non-neoplastic thymi exhibited scattered ACTH and CRH immunoreactive cells. Normal adrenal cortex and glands with bilateral nodular hyperplasia showed diffuse CRH immunoreactivity while adrenal adenomas showed no or only focal CRH immunoreactivity. Literature review showed no association between thymic NET and adrenal adenomas. The thymus contains CRH and ACTH immunoreactive cells that are probably the origin of thymic NET. Neoplasms associated with CS exhibit strong immunoreactivity for both hormones, suggesting that CRH probably plays a role in the pathogenesis of CS. As adrenals with bilateral nodular hyperplasia exhibit diffuse CRH immunoreactivity and adrenal cortical adenomas either lack this finding or show few immunoreactive cells, this marker may be useful to distinguish these lesions.

Keywords: Adrenal; Adrenocorticotropin hormone (ACTH); Corticotropin-releasing hormone (CRH); Cushing's syndrome; Neuroendocrine tumor; Thymus.

MeSH terms

  • Adrenocorticotropic Hormone / metabolism
  • Adult
  • Aged
  • Carcinoid Tumor / complications
  • Carcinoid Tumor / pathology*
  • Corticotropin-Releasing Hormone / metabolism
  • Cushing Syndrome / etiology*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neuroendocrine Cells / metabolism
  • Neuroendocrine Cells / pathology*
  • Thymus Neoplasms / complications
  • Thymus Neoplasms / pathology*
  • Young Adult

Substances

  • Adrenocorticotropic Hormone
  • Corticotropin-Releasing Hormone